Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitric Oxide for AKI Prevention in Neonates Undergoing Cardiac Surgery
NCT04259684Phase 3Withdrawn
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Oct 2019
- Primary completion
- Oct 2019
- Modality
- DNA Intercalators/Alkylators, Inhalation Devices
01
Overview
A Phase 3 trial of nitric oxide in acute kidney injury (AKI), sponsored by Cincinnati Children's Hospital Medical Center. Planned start Oct 2019; status: withdrawn.
02
Drugs
nitric oxide
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT04259684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04259684.